EU reserves 200 million more coronavirus vaccines

The European Commission announced Wednesday it has reached a deal with a sixth pharmaceutical firm, this time BioNTech-Pfizer, to reserve a further 200 million doses of a potential coronavirus vaccine. “Our chances to develop and deploy a safe and effective vaccine have never been higher, both for Europeans here at…